Enanta Pharmaceuticals Inc (ENTA)
13.50
+0.08
(+0.60%)
USD |
NASDAQ |
Apr 23, 11:33
Enanta Pharmaceuticals Cash from Operations (TTM): -92.50M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -92.50M |
September 30, 2023 | -103.15M |
June 30, 2023 | -97.09M |
March 31, 2023 | -94.56M |
December 31, 2022 | -107.15M |
September 30, 2022 | -84.78M |
June 30, 2022 | -90.27M |
March 31, 2022 | -90.17M |
December 31, 2021 | -68.38M |
September 30, 2021 | -70.00M |
June 30, 2021 | -64.44M |
March 31, 2021 | -39.42M |
December 31, 2020 | -20.16M |
September 30, 2020 | 7.088M |
June 30, 2020 | 31.09M |
March 31, 2020 | 38.12M |
December 31, 2019 | 53.53M |
September 30, 2019 | 71.42M |
June 30, 2019 | 91.21M |
March 31, 2019 | 92.73M |
December 31, 2018 | 55.06M |
September 30, 2018 | 29.22M |
June 30, 2018 | 58.18M |
Date | Value |
---|---|
March 31, 2018 | 49.34M |
December 31, 2017 | 53.92M |
September 30, 2017 | 52.65M |
June 30, 2017 | -6.779M |
March 31, 2017 | -4.095M |
December 31, 2016 | 8.961M |
September 30, 2016 | 35.81M |
June 30, 2016 | 35.56M |
March 31, 2016 | 23.47M |
December 31, 2015 | 112.28M |
September 30, 2015 | 76.67M |
June 30, 2015 | 74.12M |
March 31, 2015 | 123.43M |
December 31, 2014 | 20.44M |
September 30, 2014 | 20.18M |
June 30, 2014 | 22.61M |
March 31, 2014 | -18.43M |
December 31, 2013 | -4.263M |
September 30, 2013 | 10.65M |
June 30, 2013 | 11.45M |
March 31, 2013 | 13.55M |
December 31, 2012 | 34.86M |
September 30, 2012 | 22.62M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-107.15M
Minimum
Dec 2022
91.21M
Maximum
Jun 2019
-38.40M
Average
-68.38M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
Madrigal Pharmaceuticals Inc | -324.23M |
Galectin Therapeutics Inc | -32.96M |
Viking Therapeutics Inc | -73.38M |
Akero Therapeutics Inc | -145.37M |
89bio Inc | -129.19M |